Technical Analysis for CMRX - Chimerix, Inc.

Grade Last Price % Change Price Change
grade F 2.44 4.27% 0.10
CMRX closed up 4.27 percent on Friday, September 20, 2019, on approximately normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Up
See historical CMRX trend table...

Date Alert Name Type % Chg
Death Cross Bearish 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Weak + Overbought Other 0.00%
Outside Day Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
Bearish Engulfing Bearish 4.27%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 4.27%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 2.52%
Stochastic Reached Overbought Strength 2.52%

Older signals for CMRX ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Chimerix, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of oral antiviral therapeutics for various medical needs. Its lead product includes CMX001, an orally administered drug that has completed Phase II clinical trials for the prevention of cytomegalovirus infection in hematopoietic stem cell transplant recipients; and is in Phase II clinical trials for treating double-stranded DNA viruses comprising herpesviruses, adenoviruses, BK viruses, papillomaviruses, and orthopoxviruses, as well as for the treatment of smallpox. The company also develops CMX157, an oral nucleotide compound that is in Phase I clinical trials to treat HIV infections. It has a collaboration and license agreement with Merck, Sharp & Dohme Corp. Chimerix, Inc. was founded in 2000 and is headquartered in Durham, North Carolina.
Medicine Chemistry Biopharmaceutical Antiviral Drug Virus Antivirals Ebola Prodrugs
Is CMRX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 4.4
52 Week Low 1.74
Average Volume 377,092
200-Day Moving Average 2.7749
50-Day Moving Average 2.7655
20-Day Moving Average 2.1655
10-Day Moving Average 2.259
Average True Range 0.1459
ADX 28.98
+DI 21.0315
-DI 14.6251
Chandelier Exit (Long, 3 ATRs ) 2.1023
Chandelier Exit (Short, 3 ATRs ) 2.3477
Upper Bollinger Band 2.4474
Lower Bollinger Band 1.8836
Percent B (%b) 0.99
BandWidth 26.035558
MACD Line -0.0908
MACD Signal Line -0.1734
MACD Histogram 0.0826
Fundamentals Value
Market Cap 114.79 Million
Num Shares 47 Million
EPS -1.43
Price-to-Earnings (P/E) Ratio -1.71
Price-to-Sales 53.42
Price-to-Book 0.94
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.65
Resistance 3 (R3) 2.64 2.55 2.62
Resistance 2 (R2) 2.55 2.50 2.56 2.60
Resistance 1 (R1) 2.50 2.47 2.53 2.51 2.59
Pivot Point 2.41 2.41 2.43 2.42 2.41
Support 1 (S1) 2.36 2.36 2.39 2.37 2.29
Support 2 (S2) 2.27 2.33 2.28 2.28
Support 3 (S3) 2.22 2.27 2.27
Support 4 (S4) 2.23